China Solid Tumor Drug Market Report & Forecast 2021-2027

0
30

China Solid Tumor Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
China Solid Tumor Drug Market Segment Percentages, By Type, 2020 (%)
Small Molecules
Biologics

China Solid Tumor Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
China Solid Tumor Drug Market Segment Percentages, By Application, 2020 (%)
Oncology
Neurology
Radiology
Others

 

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Solid Tumor Drug revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Solid Tumor Drug revenues share in China market, 2020 (%)
Key companies Solid Tumor Drug sales in China market, 2016-2021 (Estimated), (K MT)
Key companies Solid Tumor Drug sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.